These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 23547262)

  • 1. Ablation of dihydroceramide desaturase 1, a therapeutic target for the treatment of metabolic diseases, simultaneously stimulates anabolic and catabolic signaling.
    Siddique MM; Li Y; Wang L; Ching J; Mal M; Ilkayeva O; Wu YJ; Bay BH; Summers SA
    Mol Cell Biol; 2013 Jun; 33(11):2353-69. PubMed ID: 23547262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ablation of dihydroceramide desaturase confers resistance to etoposide-induced apoptosis in vitro.
    Siddique MM; Bikman BT; Wang L; Ying L; Reinhardt E; Shui G; Wenk MR; Summers SA
    PLoS One; 2012; 7(9):e44042. PubMed ID: 22984457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting a ceramide double bond improves insulin resistance and hepatic steatosis.
    Chaurasia B; Tippetts TS; Mayoral Monibas R; Liu J; Li Y; Wang L; Wilkerson JL; Sweeney CR; Pereira RF; Sumida DH; Maschek JA; Cox JE; Kaddai V; Lancaster GI; Siddique MM; Poss A; Pearson M; Satapati S; Zhou H; McLaren DG; Previs SF; Chen Y; Qian Y; Petrov A; Wu M; Shen X; Yao J; Nunes CN; Howard AD; Wang L; Erion MD; Rutter J; Holland WL; Kelley DE; Summers SA
    Science; 2019 Jul; 365(6451):386-392. PubMed ID: 31273070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myristic acid increases dihydroceramide Δ4-desaturase 1 (DES1) activity in cultured rat hepatocytes.
    Ezanno H; le Bloc'h J; Beauchamp E; Lagadic-Gossmann D; Legrand P; Rioux V
    Lipids; 2012 Feb; 47(2):117-28. PubMed ID: 22139871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-Myristoylation targets dihydroceramide Delta4-desaturase 1 to mitochondria: partial involvement in the apoptotic effect of myristic acid.
    Beauchamp E; Tekpli X; Marteil G; Lagadic-Gossmann D; Legrand P; Rioux V
    Biochimie; 2009; 91(11-12):1411-9. PubMed ID: 19647031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myristic acid increases the activity of dihydroceramide Delta4-desaturase 1 through its N-terminal myristoylation.
    Beauchamp E; Goenaga D; Le Bloc'h J; Catheline D; Legrand P; Rioux V
    Biochimie; 2007 Dec; 89(12):1553-61. PubMed ID: 17716801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dihydroceramide desaturase and dihydrosphingolipids: debutant players in the sphingolipid arena.
    Fabrias G; Muñoz-Olaya J; Cingolani F; Signorelli P; Casas J; Gagliostro V; Ghidoni R
    Prog Lipid Res; 2012 Apr; 51(2):82-94. PubMed ID: 22200621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Role for Ceramides, but Not Sphingomyelins, as Antagonists of Insulin Signaling and Mitochondrial Metabolism in C2C12 Myotubes.
    Park M; Kaddai V; Ching J; Fridianto KT; Sieli RJ; Sugii S; Summers SA
    J Biol Chem; 2016 Nov; 291(46):23978-23988. PubMed ID: 27703011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dihydroceramide desaturase inhibitors induce autophagy via dihydroceramide-dependent and independent mechanisms.
    Casasampere M; Ordóñez YF; Casas J; Fabrias G
    Biochim Biophys Acta Gen Subj; 2017 Feb; 1861(2):264-275. PubMed ID: 27894925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting dihydroceramide desaturase 1 (Des1): Syntheses of ceramide analogues with a rigid scaffold, inhibitory assays, and AlphaFold2-assisted structural insights reveal cyclopropenone PR280 as a potent inhibitor.
    Rivero P; Ivanova V; Barril X; Casampere M; Casas J; Fabriàs G; Díaz Y; Matheu MI
    Bioorg Chem; 2024 Apr; 145():107233. PubMed ID: 38422591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitors of dihydroceramide desaturase 1: Therapeutic agents and pharmacological tools to decipher the role of dihydroceramides in cell biology.
    Casasampere M; Ordoñez YF; Pou A; Casas J
    Chem Phys Lipids; 2016 May; 197():33-44. PubMed ID: 26248324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Very long chain ceramides interfere with C16-ceramide-induced channel formation: A plausible mechanism for regulating the initiation of intrinsic apoptosis.
    Stiban J; Perera M
    Biochim Biophys Acta; 2015 Feb; 1848(2):561-7. PubMed ID: 25462172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dihydroceramide-desaturase-1-mediated caspase 9 activation through ceramide plays a pivotal role in palmitic acid-induced HepG2 cell apoptosis.
    Zhu Q; Yang J; Zhu R; Jiang X; Li W; He S; Jin J
    Apoptosis; 2016 Sep; 21(9):1033-44. PubMed ID: 27364952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sphingolipid imbalance and inflammatory effects induced by uremic toxins in heart and kidney cells are reversed by dihydroceramide desaturase 1 inhibition.
    Savira F; Magaye R; Scullino CV; Flynn BL; Pitson SM; Anderson D; Creek DJ; Hua Y; Xiong X; Huang L; Liew D; Reid C; Kaye D; Kompa AR; Wang BH
    Toxicol Lett; 2021 Oct; 350():133-142. PubMed ID: 34303789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential regulation of dihydroceramide desaturase by palmitate versus monounsaturated fatty acids: implications for insulin resistance.
    Hu W; Ross J; Geng T; Brice SE; Cowart LA
    J Biol Chem; 2011 May; 286(19):16596-605. PubMed ID: 21454530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell density-dependent reduction of dihydroceramide desaturase activity in neuroblastoma cells.
    Spassieva SD; Rahmaniyan M; Bielawski J; Clarke CJ; Kraveka JM; Obeid LM
    J Lipid Res; 2012 May; 53(5):918-928. PubMed ID: 22377532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fenretinide prevents lipid-induced insulin resistance by blocking ceramide biosynthesis.
    Bikman BT; Guan Y; Shui G; Siddique MM; Holland WL; Kim JY; Fabriàs G; Wenk MR; Summers SA
    J Biol Chem; 2012 May; 287(21):17426-17437. PubMed ID: 22474281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dihydroceramide desaturase 1 (DES1) promotes anchorage-independent survival downstream of HER2-driven glucose uptake and metabolism.
    Linzer RW; Guida DL; Aminov J; Snider JM; Khalife G; Buyukbayraktar AB; Alhaddad C; Resnick AE; Wang P; Pan CH; Allopenna JJ; Clarke CJ
    FASEB J; 2022 Oct; 36(10):e22558. PubMed ID: 36165222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dihydroceramide desaturase 1, the gatekeeper of ceramide induced lipotoxicity.
    Rodriguez-Cuenca S; Barbarroja N; Vidal-Puig A
    Biochim Biophys Acta; 2015 Jan; 1851(1):40-50. PubMed ID: 25283058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dihydroceramide desaturase knockdown impacts sphingolipids and apoptosis after photodamage in human head and neck squamous carcinoma cells.
    Breen P; Joseph N; Thompson K; Kraveka JM; Gudz TI; Li L; Rahmaniyan M; Bielawski J; Pierce JS; VAN Buren E; Bhatti G; Separovic D
    Anticancer Res; 2013 Jan; 33(1):77-84. PubMed ID: 23267130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.